Loading...
MON-LB079 A Multicenter, Randomized, Open-Label, Phase IV Study Investigating Management of Pasireotide-Associated Hyperglycemia with Incretin-Based Therapy or Insulin in Patients with Acromegaly or Cushing's Disease (CD)
Background: Pasireotide has proven efficacy in acromegaly and CD, although pasireotide-associated hyperglycemia occurs in some patients (pts). We present results from a Phase IV, randomized, open-label study investigating optimal management of pasireotide-associated hyperglycemia uncontrolled by met...
Na minha lista:
| Udgivet i: | J Endocr Soc |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Endocrine Society
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6550842/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-MON-LB079 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|